phleomycins has been researched along with leupeptins in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Jackson, SP; Masterson, P; Moumen, A; O'Connor, MJ | 1 |
1 other study(ies) available for phleomycins and leupeptins
Article | Year |
---|---|
hnRNP K: an HDM2 target and transcriptional coactivator of p53 in response to DNA damage.
Topics: Animals; Ataxia Telangiectasia Mutated Proteins; Cell Cycle; Cell Cycle Proteins; Cell Line; Cell Line, Tumor; Cyclin-Dependent Kinase Inhibitor p21; Cysteine Proteinase Inhibitors; DNA Damage; DNA-Binding Proteins; Gene Expression; Heterogeneous-Nuclear Ribonucleoprotein K; Humans; Leupeptins; Morpholines; Phleomycins; Promoter Regions, Genetic; Proteasome Endopeptidase Complex; Proteasome Inhibitors; Protein Binding; Protein Kinase Inhibitors; Protein Serine-Threonine Kinases; Proto-Oncogene Proteins c-mdm2; Pyrones; Radiation, Ionizing; Ribonucleoproteins; RNA, Small Interfering; Transcription, Genetic; Transfection; Tumor Suppressor Protein p53; Tumor Suppressor Proteins; Ubiquitin; Ultraviolet Rays | 2005 |